Share on StockTwits

ArQule (NASDAQ:ARQL) posted its quarterly earnings results on Wednesday. The company reported ($0.11) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.11), AnalystRatings.NET reports.

ArQule (NASDAQ:ARQL) opened at 1.51 on Wednesday. ArQule has a 52 week low of $1.51 and a 52 week high of $3.05. The stock’s 50-day moving average is $1.85 and its 200-day moving average is $2.14. The company’s market cap is $94.9 million. ArQule also saw a large increase in short interest in April. As of April 15th, there was short interest totalling 2,428,218 shares, an increase of 41.1% from the March 31st total of 1,720,542 shares. Based on an average daily trading volume, of 364,666 shares, the days-to-cover ratio is currently 6.7 days. Currently, 4.6% of the shares of the stock are sold short.

ArQule, Inc is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.